An employer-based, pharmacist intervention model for patients with type 2 diabetes.

Purpose: Changes in glycosylated hemoglobin (HbA(1c)) levels, blood pressure measurements, and utilization metrics among diabetic patients managed by a clinical pharmacist were studied.

Summary: This pharmacist intervention model was developed by Polk County, Florida, to engage patients with diabetes in managing their health based on the Asheville Project's framework. The diabetes program was implemented in February 2005, with an on-site clinical pharmacist to counsel participants with diabetes.